Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: Risk of relatively severe congenital malformations or cardiac defects. A register study

BMJ Open

Volumn 3, Issue 2, 2013, Pages

  Reis, Margareta ^a   Källén, Bengt ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF LUND   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; HYPNOTIC SEDATIVE AGENT; INSULIN; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; RISK; TERATOGENICITY;

EID: 84874977837     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002166     Document Type: Article

References (10)

1. Reis M, Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010;10:1723-33.
2. Oberlander TF, Warburton W, Misri S, et al. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 2008;83:68-76. (Pubitemid 351317794)
3. National Board of Health and Welfare. Centre for Epidemiology. The Swedish Medical Birth Register - a summary of content and quality. 2003. http://www.socialstyrelsen.se/Publikationer2003/-112-3 (accessed 29 May 2012).
4. Källén B, Otterblad Olausson P. Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias? Int J Risk Safety Med 2001;14:115-19. (Pubitemid 35024885)
5. National Board of Health and Welfare. Centre for Epidemiology. Registration of congenital malformations in Swedish health registers. 2004. http://www.socialstyrelsen.se/Publikationer2004/2004-112-1 (accessed 29 May 2012).
6. Källén B. Drugs during pregnancy. New York, NY: Nova Biomedical Books, 2009.
7. Yang J, Cummings EA, O'Connel C, et al. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 2006;108:644-50. (Pubitemid 44337107)
8. Lennestål R, Otterblad Olausson P, Källén B. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 2009;65:615-25.
9. Wikner BN, Sparre LS, Stiller CO, et al. Maternal use of thyroid hormones in pregnancy and neonatal outcome. Acta Obstet Gynecol 2008;87:617-27.
10. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants. Eur J Clin Pharmacol 2007;63:383-8. (Pubitemid 46399130)